A therapeutic HPV vaccine could eliminate precancerous cervical lesions, clinical trial suggests

by

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a Phase II clinical trial published in Clinical Cancer Research.

Leave A Comment

Your email address will not be published. Required fields are marked *